中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 40 Issue 2
Feb.  2024
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(2): 335-342

Effect of Dendrobium officinale leaf fermentation fluid on a mouse model of alcoholic hepatitis and its mechanism of action

DOI: 10.12449/JCH240218
  • 1.

    Department of Infectious Diseases，The Affiliated Hospital of Guizhou Medical University，Guiyang 550001，China

  • 2.

    School of Clinical Medicine，Guizhou Medical University，Guiyang 550001，China

Research funding:

National Natural Science Foundation of China (82060123);

Guizhou Provincial Health Commission (gzwjk2019-1-082);

Foundation of Guizhou Science and Technology Department (［2020］1Y299);

National Nature Cultivation Project of Affiliated Hospital of Guizhou Medical University (I-2020-12);

Doctoral Foundation of Affiliated Hospital of Guizhou Medical University (gyfybsky-2021-28)

More Information
  • Corresponding author: LI Hong， 625062102@qq.com （ORCID： 0000-0003-0601-3198）
  • Received Date: 2023-05-17
  • Accepted Date: 2023-06-26
  • Published Date: 2024-02-19
    Abstract
  •   Objective  To investigate the intervention mechanism of Dendrobium officinale leaf fermentation fluid in mice with alcoholic hepatitis.  Methods  A total of 70 healthy male C57BL/6J mice， aged 6-8 weeks， were randomly divided into normal group， model group， liquid feed control group， silybin group， and low-， middle-， and high-dose Dendrobium officinale leaf fermentation fluid groups， with 10 mice in each group. The mice in the normal group were given normal diet， and those in the other groups were given Lieber-DeCarli classic liquid diet for 8 weeks to induce alcoholic hepatitis. During modeling， the mice in the low-， middle-， and high-dose Dendrobium officinale leaf fermentation fluid groups were given Dendrobium liquid manufactured by Warmen Pharmaceutical， and the mice in all the other groups were given pure water； the mice in the normal group， the model group， and the liquid feed control group were given normal saline by gavage， those in the silybin group were given silybin 0.25 mL/10 g by gavage， and those in the low-， middle-， and high-dose Dendrobium officinale leaf fermentation fluid groups were given Dendrobium officinale leaf fermentation fluid at a dose of 0.125 mL/10 g， 0.250 mL/10 g， and 0.375 mL/10 g， respectively， by gavage， once a day. At week 8， chloral hydrate was injected intraperitoneally for anesthesia， and blood samples were collected from the eyeball. After serum was separated， the biochemical method was used to measure the levels of aspartate aminotransferase （AST） and alanine aminotransferase （ALT）； HE staining and oil red staining were used to observe liver histopathology and lipid accumulation in mice； multiplex Luminex assay was used to measure the serum levels of interleukin-6 （IL-6）， interleukin-1β （IL-1β）， tumor necrosis factor-α （TNF-α）， and CCL2； quantitative real-time PCR， Western blot， and immunofluorescence assay were used to measure the protein expression levels of NLRP3， caspase-1， caspase-11， gasdermin D （GSDMD）， N-terminal gasdermin D （GSDMD-N） in liver tissue. A one-way analysis of variance was used for comparison of continuous data between multiple groups， and the least significant difference t-test was used for further comparison between two groups.  Results  Compared with the normal group， the model group had significant increases in the serum levels of AST， ALT， IL-6， IL-1β， TNF-α， and CCL2 （all P<0.05）， and compared with the model group， the high-dose Dendrobium officinale leaf fermentation fluid group had significant reductions in the serum levels of AST， ALT， IL-6， IL-1β， TNF-α， and CCL2 （all P<0.05）. HE staining showed that the model group had disordered structure of hepatic lobules， with a large number of steatosis vacuoles and massive cell necrosis， and compared with the model group， the high-dose Dendrobium officinale leaf fermentation fluid group had alleviation of liver histopathological injury， intact structure of most hepatic lobules， and a small amount of inflammatory cell infiltration. Oil red staining showed that the model group had accumulation of large and small lipid droplets in the liver and a significant increase in liver fat content， and compared with the model group， the high-dose Dendrobium officinale leaf fermentation fluid group had significant alleviation of hepatic steatosis， with the presence of sporadic small lipid droplets. Immunofluorescence assay of liver tissue showed that compared with the normal group， the model group had a significant increase in the ratio of GSDMD-positive staining area in hepatocyte cytoplasm （P<0.001）， and compared with the model group， the high-dose Dendrobium officinale leaf fermentation fluid group had a significant reduction in such ratio in hepatocyte cytoplasm （P<0.001）. Quantitative real-time PCR showed that compared with the normal group， the model group had significant increases in the protein expression levels of NLRP3， caspase-1， caspase-11， GSDMD， GSDMD-N， interleukin-18 （IL-18）， and IL-1β in liver tissue （all P<0.05）， and compared with the model group， the high-dose Dendrobium officinale leaf fermentation fluid group had significant reductions in the protein expression levels of NLRP3， caspase-1， caspase-11， GSDMD， GSDMD-N， IL-18， and IL-1 （all P<0.05）. Compared with the model group， the high-dose Dendrobium officinale leaf fermentation fluid group had significant reductions in the protein expression levels of caspase-1 and caspase-11 （both P<0.05）， with a relative expression level of caspase-1 of 1.757 （reduced by 26.6% compared with the model group） and a relative expression level of caspase-11 of 0.455 （reduced by 70.3% compared with the model group）， suggesting that caspase-11 showed a greater reduction than caspase-1.  Conclusion  Dendrobium officinale leaf fermentation fluid can alleviate alcoholic hepatitis in mice， possibly by inhibiting the non-classical cell pyroptosis pathway mediated by caspase-11.

     

    • FullText(HTML)
    • References(16)
  • [1]
    ALTAMIRANO J, BATALLER R. Alcoholic liver disease: Pathogenesis and new targets for therapy[J]. Nat Rev Gastroenterol Hepatol, 2011, 8( 9): 491- 501. DOI: 10.1038/nrgastro.2011.134.
    [2]
    SHI JJ, ZHAO Y, WANG K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526( 7575): 660- 665. DOI: 10.1038/nature15514.
    [3]
    LIU X, XIA SY, ZHANG ZB, et al. Channelling inflammation: Gasdermins in physiology and disease[J]. Nat Rev Drug Discov, 2021, 20( 5): 384- 405. DOI: 10.1038/s41573-021-00154-z.
    [4]
    AMBADE A, LOWE P, KODYS K, et al. Pharmacological inhibition of CCR2/5 signaling prevents and reverses alcohol-induced liver damage, steatosis, and inflammation in mice[J]. Hepatology, 2019, 69( 3): 1105- 1121. DOI: 10.1002/hep.30249.
    [5]
    FENG LJ, LIU KY, QUAN HQ. Study on main composition and content determination of Dendrobium candidum[J]. Farm Prod Process, 2023( 6): 85- 87. DOI: 10.16693/j.cnki.1671-9646(X).2023.03.049.

    冯柳娟, 刘凯月, 全海倩. 铁皮石斛主要成分及其含量检测方法的研究[J]. 农产品加工, 2023( 6): 85- 87. DOI: 10.16693/j.cnki.1671-9646(X).2023.03.049.
    [6]
    LIU YG, YANG LL, ZHANG Y, et al. Dendrobium officinale polysaccharide ameliorates diabetic hepatic glucose metabolism via glucagon-mediated signaling pathways and modifying liver-glycogen structure[J]. J Ethnopharmacol, 2020, 248: 112308. DOI: 10.1016/j.jep.2019.112308.
    [7]
    CHU WH, WANG P, MA Z, et al. Ultrasonic treatment of Dendrobium officinale polysaccharide enhances antioxidant and anti-inflammatory activity in a mouse D-galactose-induced aging model[J]. Food Sci Nutr, 2022, 10( 8): 2620- 2630. DOI: 10.1002/fsn3.2867.
    [8]
    YANG K, ZHAN LH, LU TT, et al. Dendrobium officinale polysaccharides protected against ethanol-induced acute liver injury in vivo and in vitro via the TLR4/NF-‍κB signaling pathway[J]. Cytokine, 2020, 130: 155058. DOI: 10.1016/j.cyto.2020.155058.
    [9]
    YUAN C, LIAN QH, NI BB, et al. Screening and bioinformatics analysis of key autophagy-related genes in alcoholic hepatitis[J]. Ogran Transplant, 2024, 15( 1): 90- 101.

    袁超, 练庆海, 尼贝贝, 等. 酒精性肝炎自噬关键基因的筛选及生物信息学分析[J]. 器官移植, 2024, 15( 1): 90- 101.
    [10]
    XU H, XIAO P, ZHANG F, et al. Epidemic characteristics of alcohol-related liver disease in Asia from 2000 to 2020: A systematic review and meta-analysis[J]. Liver Int, 2022, 42( 9): 1991- 1998. DOI: 10.1111/liv.15312.
    [11]
    SUNG H, KIM SW, HONG M, et al. Microbiota-based treatments in alcoholic liver disease[J]. World J Gastroenterol, 2016, 22( 29): 6673- 6682. DOI: 10.3748/wjg.v22.i29.6673.
    [12]
    YI YS. Caspase-11 non-canonical inflammasome: A critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses[J]. Immunology, 2017, 152( 2): 207- 217. DOI: 10.1111/imm.12787.
    [13]
    KHANOVA E, WU R, WANG W, et al. Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients[J]. Hepatology, 2018, 67( 5): 1737- 1753. DOI: 10.1002/hep.29645.
    [14]
    HEO MJ, KIM TH, YOU JS, et al. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression[J]. Gut, 2019, 68( 4): 708- 720. DOI: 10.1136/gutjnl-2017-315123.
    [15]
    WU YL, HUANG SH, HE CM, et al. Dendrobium officinale flower extraction mitigates alcohol-induced liver injury in mice: Role of antisteatosis, antioxidative, and anti-inflammatory[J]. Evid Based Complement Alternat Med, 2020, 2020: 1421853. DOI: 10.1155/2020/1421853.
    [16]
    YUAN HQ, LIANG CY, LIANG J, et al. Protection of Dendrobium Officinale against acute alcoholic liver injury in mice[J]. J Jinan Univ Nat Sci Med Ed, 2016, 37( 5): 384- 388. DOI: 10.11778/j.jdxb.2016.05.005.

    袁慧琦, 梁楚燕, 梁健, 等. 铁皮石斛对小鼠急性酒精性肝损伤的保护作用[J]. 暨南大学学报(自然科学与医学版), 2016, 37( 5): 384- 388. DOI: 10.11778/j.jdxb.2016.05.005.
    • Relative Articles

  • Relative Articles

    [1]Chenlu HAN, Haijun LIANG, Daokun YANG, Haiyan CHANG, Shuai WEI, Xingwei WANG, Haili GAO. Expression levels of serum high-mobility group box 1， soluble CD163， and prostaglandin E2 in patients with hepatitis B virus-related chronic-on-acute liver failure and their value in predicting prognosis[J]. Journal of Clinical Hepatology, 2024, 40(6): 1130-1135. doi: 10.12449/JCH240610
    [2]Chen Hao, Hao JianHeng, Li ZhenCheng, Xu HuiChao, Gao Yan, Miao YuChuan, Hao HuiQin, Liu Yang. Screening for differentially expressed genes in mice with autoimmune hepatitis and effect of saikosaponin-d on the expression of several differentially expressed genes[J]. Journal of Clinical Hepatology, 2020, 36(4): 840-846. doi: 10.3969/j.issn.1001-5256.2020.04.026
    [3]Tang Ling, Qiu LuDie, Qin Wen, Wu Gang. Expression of circular RNA FLI1 in patients with hepatocellular carcinoma and its association with prognosis[J]. Journal of Clinical Hepatology, 2019, 35(9): 1980-1984. doi: 10.3969/j.issn.1001-5256.2019.09.019
    [4]Fan Bin, Zhang Yong, Li JinMao, Liu Tao, Zhang JiaYao. Association between the expression of centromere protein F and prognosis in patients with hepatocellular carcinoma:An analysis using GEO database[J]. Journal of Clinical Hepatology, 2018, 34(7): 1475-1480. doi: 10.3969/j.issn.1001-5256.2018.07.022
    [5]Yang XinYing, Kang FuBiao, Ye LiHong, Dai ErHei, Sun DianXing. Level of high-mobility group box 1 in patients with chronic hepatitis B and liver cirrhosis and its clinical significance[J]. Journal of Clinical Hepatology, 2018, 34(9): 1901-1904. doi: 10.3969/j.issn.1001-5256.2018.09.015
    [6]Xiao ChunYang, Li QinKai, Yu JingXia, Liu Ting, Lu LunGen, Xu MingYi. Risk genes for the development of chronic hepatitis B cirrhosis assessed by prediction analysis of microarrays[J]. Journal of Clinical Hepatology, 2016, 32(7): 1323-1329. doi: 10.3969/j.issn.1001-5256.2016.07.022
    [7]Zhang JiCai, Yu ZongTao, Lyu Jun, Li HaiPing, Gao Bo. Relationship between HBV infection and DNMT expression in liver cancer tissues[J]. Journal of Clinical Hepatology, 2013, 29(8): 620-623. doi: 10.3969/j.issn.1001-5256.2013.08.017
    [8]Ye Chao, Chen YongPing, Dai ZhiJuan, Li WenYuan, Lin Zhuo, Cheng Yuan, Jin XiaoZhi. Dynamic expression of β-catenin in rat models of hepatic fibrosis and its significance[J]. Journal of Clinical Hepatology, 2011, 27(3): 261-264.
    [9]Liu QiSheng, Xu XiaoHong, Liu Huai. Expression of Plk1 and Survivin in hepatocellular carcinoma and its significance[J]. Journal of Clinical Hepatology, 2011, 27(4): 397-399.
    [10]Gao BaoHua, Liu Bing, Zheng JianYun, Wu FangXiong, Wang Wen, Li Lei, Niu ChunYan. The study of the expression of COX-2 and CDKN2A in chronic hepatitis B and liver cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 273-276.
    [11]Li HaiPing, Tao JianShu, Gao Bo, Yu ZongTao, Li WenCui, Zhang JiCai. The expression and clinical significance of resistance gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(9): 972-975.
    [12]Niu ChunYan, Zheng JianYun, Li Lei, Gao BaoHua, Liu Bing, Luo JianMei. The expression and significance of HMGB1 in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(8): 807-809.
    [13]Zhang Zhe, Guo JinSheng. The role of high mobility group box 1 in human liver diseases[J]. Journal of Clinical Hepatology, 2011, 27(10): 1116-1120.
    [14]Chen LiDong, Cheng Jun, Hong Yuan, Zhang LianFeng, Han Li, Guo Jiang. Construction of the prokaryotic expression vector of NS5ATP4A gene and its expression[J]. Journal of Clinical Hepatology, 2010, 26(4): 371-373.
    [15]Cheng LiangBin, Cheng Ming, Liu Yan. The effect of Kangxian ruangan granule on the expression of nuclear factor-κB gene in fibrotic rat liver[J]. Journal of Clinical Hepatology, 2010, 26(4): 410-412.
    [16]Wu ShiPin, Liu ZhenZhen, Zhou Jun, Huang MingHui. Analysis of differential gene expression profiles in hepatic fibrosis tissue using cDNA microarray[J]. Journal of Clinical Hepatology, 2007, 23(4): 258-260.
    [18]Lu DongDong, Zhang XiRan. The primary study of expression and function of CK2α subunit in liver cancer[J]. Journal of Clinical Hepatology, 2003, 19(4): 240-241.
    [19]Wang AiMin, Wang BaoEn, Yang YueWei, Zhang Bin, Jiang LongAn, Du ShuangCun. Interstitial collagenase gene expression in patients with chronic liver disease[J]. Journal of Clinical Hepatology, 2000, 16(2): 90-91+124.
    • Supplements(0)
    • Cited By
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 5.0 %FULLTEXT: 5.0 %META: 86.1 %META: 86.1 %PDF: 8.9 %PDF: 8.9 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.2 %其他: 4.2 %其他: 1.1 %其他: 1.1 %Astoria: 0.3 %Astoria: 0.3 %Central District: 0.8 %Central District: 0.8 %Seattle: 0.3 %Seattle: 0.3 %Sweden: 0.6 %Sweden: 0.6 %上海: 4.7 %上海: 4.7 %东莞: 0.3 %东莞: 0.3 %京都: 0.6 %京都: 0.6 %北京: 10.5 %北京: 10.5 %北苏门答腊: 0.3 %北苏门答腊: 0.3 %南宁: 0.3 %南宁: 0.3 %厦门: 0.3 %厦门: 0.3 %台州: 0.3 %台州: 0.3 %吉林: 7.2 %吉林: 7.2 %广州: 0.8 %广州: 0.8 %张家口: 2.8 %张家口: 2.8 %意法半: 0.6 %意法半: 0.6 %成都: 0.3 %成都: 0.3 %揭阳: 0.3 %揭阳: 0.3 %昆明: 1.1 %昆明: 1.1 %杭州: 0.6 %杭州: 0.6 %武汉: 0.3 %武汉: 0.3 %泰州: 0.3 %泰州: 0.3 %深圳: 0.6 %深圳: 0.6 %温州: 0.3 %温州: 0.3 %湖州: 0.6 %湖州: 0.6 %石家庄: 0.3 %石家庄: 0.3 %芒廷维尤: 30.7 %芒廷维尤: 30.7 %莫斯科: 0.8 %莫斯科: 0.8 %葵涌: 0.3 %葵涌: 0.3 %衢州: 0.3 %衢州: 0.3 %西宁: 25.8 %西宁: 25.8 %长春: 1.7 %长春: 1.7 %香港: 0.3 %香港: 0.3 %其他其他AstoriaCentral DistrictSeattleSweden上海东莞京都北京北苏门答腊南宁厦门台州吉林广州张家口意法半成都揭阳昆明杭州武汉泰州深圳温州湖州石家庄芒廷维尤莫斯科葵涌衢州西宁长春香港

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(8)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (641) PDF downloads(65) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2329]YesterdayPV[4431]TodayIP[273]TodayPV[408]Online[28]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return